January 30, 2023
(Reuters) – Regeneron Pharmaceuticals Inc forecast U.S. sales of eye drug Eylea to reach $1.7-$1.8 billion in 2014 as it expects the drug to win approval for newer uses, sending its shares up 3…
Your email address will not be published.
Save my name, email, and website in this browser for the next time I comment.